CAMP vs PATH
CAMP4 THERAPEUTICS CORPORATION (CAMP) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
CAMP4 THERAPEUTICS CORPORATION (CAMP) is a biotechnology company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported CAMP revenue for 2024-12-31 was $652.0K. Net income was -$51.8M. Revenue was up 86.3% from 2023-12-31 to 2024-12-31. CAMP currently screens at market cap $215.0M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
CAMP currently screens at market cap $215.0M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the CAMP and PATH stock pages for the full models.
Not investment advice.